首页> 外文期刊>International immunopharmacology >Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-kappa B and JAK/STAT signaling pathways in rats
【24h】

Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-kappa B and JAK/STAT signaling pathways in rats

机译:通过抑制大鼠NF-Kappa B和Jak / Stat信号传导途径来抑制炎症和氧化胁迫,STOHYDRINE改善异丙醇诱导的心脏肥厚和纤维化

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac hypertrophy (CH), as one of the major causes of morbidity and mortality in the world, has become an independent and predictive risk factor for adverse cardiovascular events. However, progress in treatment remains sluggish in recent years. Therefore, compounds derived from non-toxic nature plants are urgently needed. Stachydrine (STA), which is isolated from Leonurus, has various activities, including resistance to cardiovascular disease, but little is known about its effect on CH or the mechanisms. We herein investigated the effect of STA on isoproterenol-induced CH and the underlying mechanisms. Treatment with STA significantly increased the ratios of heart weight/body weight, left ventricle weight/body weight and the cross-sectional areas of cardiomyocytes. In addition, STA significantly decreased the mRNA levels of atrial natriuretic peptide, B-type natriuretic peptide and beta-myosin heavy chain. Furthermore, isoproterenol-induced fibrosis in rats receiving STA was significant attenuated, as evidenced by decreased ratio of fibrotic area/total area and decreased mRNA levels of collagens I and III. Given down-regulation of interleukin-6, tumor necrosis factor-alpha, interferon-gamma (IFN-gamma) and IFN-1 beta, treatment with STA significantly reversed the expressions of pro-inflammatory induced by isoproterenol. Moreover, STA attenuated the oxidative stress level in serum of isoproterenol-induced CH rats, as shown by increased activity of superoxide dismutase and decreased malondialdehyde level. STA inhibited the expressions of phosphorylated I kappa B alpha, NF-kappa B p65, JAK2 and STAT3 in vivo. Thus, both NF-kappa B and JAK/STAT signalings played essential roles in mediating the anti-CH effect of STA. Collectively, STA has a potent protective effect on isoproterenol-induced CH, with therapeutic implication for CH.
机译:心肺肥大(CH)是世界上发病率和死亡率的主要原因之一,已成为不良心血管事件的独立和预测的危险因素。然而,近年来,治疗进展仍然存在迟缓。因此,迫切需要衍生自无毒性质植物的化合物。与Leonurus分离的Stachydrine(STA)具有各种活动,包括抗心血管疾病,但对其对CH或机制的影响很少。我们在此研究了STA对异丙醇诱导的CH和潜在机制的影响。用STA治疗显着增加了心脏重量/体重的比率,左心室重量/体重和心肌细胞的横截面积。此外,STA显着降低了心房利钠肽的mRNA水平,B型利钠肽和β-霉菌重链。此外,接受STA大鼠的异丙醇诱导的纤维化显着减弱,如纤维化区域/总面积的降低和胶原蛋白I和III的mRNA水平降低。鉴于白细胞介素-6的下调,肿瘤坏死因子-α,干扰素-γ(IFN-γ)和IFN-1β,用STA治疗显着逆转异丙肾上腺素诱导的促炎的表达。此外,STA衰减异丙肾上腺素诱导的CH大鼠血清中的氧化应激水平,如超氧化物歧化酶的活性增加和丙二醛水平降低。 STA抑制了体内磷酸化I kappaBα,NF-Kappa B p65,JAK2和Stat3的表达。因此,NF-Kappa B和Jak / STAT信令都在介导STA的抗CH效果中发挥了重要作用。总的来说,STA对异丙酚诱导的CH具有有效的保护作用,具有CH的治疗含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号